Researchers find new clues to understanding the progression of primary membranous nephropathy
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of ...
Tag: Therapeutics
Rogue immune cell found to cause poor antibody responses in chronic viral infections
Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections. ...
Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with ...
Study highlights global fertility decline and its implications for the future
The world is approaching a low-fertility future. Although by 2100 more than 97% of countries and territories will have fertility ...
Mapping the Microbiome: Dr. Abidemi Junaid on the Groundbreaking Vagina Chip
In this insightful interview from SLAS 2024, we talk with Dr. Abidemi Junaid, a scientist at the Hansjörg Wyss Institute for ...
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the data ...
Microbial signatures linked to immunotherapy response across cancers
The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract ...
Researchers introduce a pioneering approach to combat neurodegenerative diseases
Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such ...
Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a-service (SaaS), end-to-end clinical data science ...
Unlocking Alzheimer's secrets: Study pinpoints APOE4's harmful effect on lipids
UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have ...
POPULAR NEWS
